GENISE GREEN: Open Payments
NPI 1265768329 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,708 in 28 payments from 5 companies in 2025. Trend: 2023 $361 · 2024 $548 · 2025 $4,708
Consulting: $2,081Travel & lodging: $1,415Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 13 | $2,954 |
| E.R. Squibb & Sons, L.L.C. | 8 | $1,282 |
| BridgeBio Pharma, Inc. | 4 | $238 |
| Amgen Inc. | 1 | $145 |
| AstraZeneca Pharmaceuticals LP | 2 | $89 |
Products named: AMVUTTRA, Attruby, CAMZYOS, WAINUA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
